Who owns NEUBASE THERAPEUTICS INC?
- CUSIP Number: 64132k201
Tip: Access positions for across all investors
Analyze quarterly positions in Neubase Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neubase Therapeutics stock
Who bought or sold NEUBASE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Baader Bank | 16k | $5.0k | 100% | Jun 2024 |
|
| Springbok Capital Management | 16k | $7.0k | 100% | Mar 2024 |
|
| UBS Group | 4.1k | $1.8k | -94% | Mar 2024 |
|
| Advisor Group Holdings | 22.00 | $9.999000 | 0% | Mar 2024 |
|
| Newbridge Financial Services Group | 12.00 | $5.000400 | 0% | Mar 2024 |
|
Who sold out of Neubase Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DME Capital Management | Mar 2024 | 136k | $61k |
| Renaissance Technologies | Mar 2024 | 88k | $40k |
| Point72 Asset Management | Mar 2024 | 63k | $28k |
| Carnegie Mellon University | Mar 2024 | 47k | $21k |
| Vanguard Group | Mar 2024 | 19k | $8.5k |
| Geode Capital Management | Mar 2024 | 16k | $6.8k |
| Tower Research Capital | Mar 2024 | 2.6k | $1.2k |
| Cubist Systematic Strategies | Mar 2024 | 1.3k | $562.950000 |
| Bank of America Corporation | Mar 2024 | 804.00 | $371.046000 |
| First Manhattan | Mar 2024 | 353.00 | $158.002800 |
| Royal Bank of Canada | Mar 2024 | 153.00 | $0 |
| Wells Fargo & Company | Mar 2024 | 79.00 | $34.760000 |
| Pnc Financial Services | Mar 2024 | 21.00 | $9.000600 |